Clinical Trial Update: A Study of Tarceva (Erlotinib) to Compare Two Different Doses in in Currently Smoking Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (CURRENTS) [Phase 3]

View source ↗

Summary

A Phase 3 trial (CURRENTS) comparing two Tarceva (erlotinib) dose regimens in current smokers with advanced or metastatic non-small cell lung cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-02-23